Structure (9c376fb6 5d19 4977 B152 0db8d2664c2d 01)
Ranolazine Tablet, Extended Release
Product Images NDC 72578-064
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 72578-064). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Viona Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container Label 500mg (9c376fb6 5d19 4977 B152 0db8d2664c2d 02)
This is a description for Ranolazine Extended-Release Tablets, 500mg. It is a prescription drug manufactured by Catla Healthcare Ltd, India, and distributed by Viona Pharmaceuticals Inc, Cranford, NJ, 07016. The usual dosage should be checked against the package insert for complete prescribing information. The tablets should not be crushed, broken or chewed, and should be swallowed whole. It is recommended that they be stored between 20°C to 25°C (68°F to 77°F) and kept out of the reach of children.*
Container Label 1000mg (9c376fb6 5d19 4977 B152 0db8d2664c2d 03)
HPT204 2069789 is a prescription drug called Ranolazine Extended-Release Tablets. Each film-coated extended-release tablet contains 1000 mg of Ranolazine. It is important to swallow the tablets whole without crushing, breaking, or chewing. The usual dosage can be found in the package insert. It should be stored between 20°C to 25°C and dispensed in an airtight container. Manufactured by Cadia Healicare Ltd., India, and distributed by Viona Pharmaceuticals Inc., Cranford, NJ 07016. Keep this medicine away from children’s reach.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
